Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2019-10-23 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −20,000 780,000
2019-07-01 Cohen Chad M Chief Financial Officer Purchase +1,000 $20.00 $20K 1,000
2019-07-01 HILL NANCY LOUISE Sr Vice President, Operations Purchase +10,000 $20.00 $200K 10,000
2019-07-01 HILL NANCY LOUISE Sr Vice President, Operations Purchase +500 $20.00 $10K 500
2019-07-01 HILL NANCY LOUISE Sr Vice President, Operations Purchase +400 $20.00 $8K 400
2019-07-01 HILL NANCY LOUISE Sr Vice President, Operations Purchase +300 $20.00 $6K 300
2019-07-01 ZOLTNERS ANDRIS A Director Conversion +300,000 300,000
2019-07-01 ZOLTNERS ANDRIS A Director Conversion +992,583 1,292,583
2019-07-01 ZOLTNERS ANDRIS A Director Conversion +1,895,806 3,188,389
2019-07-01 ZOLTNERS ANDRIS A Director Conversion +454,545 3,642,934
2019-07-01 ZOLTNERS ANDRIS A Director Conversion +223,082 3,866,016
2019-07-01 ZOLTNERS ANDRIS A Director Conversion · Series A Preferred Stock −300,000 0
2019-07-01 ZOLTNERS ANDRIS A Director Conversion · Series B Preferred Stock −992,583 0
2019-07-01 ZOLTNERS ANDRIS A Director Conversion · Series C Preferred Stock −1,895,806 0
2019-07-01 ZOLTNERS ANDRIS A Director Conversion · Series E-1 Preferred Stock −454,545 0
2019-07-01 ZOLTNERS ANDRIS A Director Conversion · Series F Preferred Stock −223,082 0
2019-07-01 ROBINS CHAD M CEO and Chairman Conversion +70,680 1,858,180
2019-07-01 ROBINS CHAD M CEO and Chairman Conversion · Series E-1 Preferred Stock −70,680 0
2019-07-01 ROBINS HARLAN S Chief Scientific Officer Conversion +70,679 70,679
2019-07-01 ROBINS HARLAN S Chief Scientific Officer Conversion · Series E-1 Preferred Stock −70,679 0

Page 118 of 120 · 2,386 trades